| Authors: |
Cloughesy TF; Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA., van den Bent MJ; Brain Tumour Center, Erasmus Medical Center, Rotterdam, Netherlands., Touat M; Service de Neuro-oncologie, Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris Sorbonne Université, Paris, France., Blumenthal DT; Neuro-oncology Service, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel., Peters KB; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Ellingson BM; Department of Radiology, University of California Los Angeles, Los Angeles, CA, USA., Clarke JL; Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Mendez J; Department of Neurosurgery, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA., Yust-Katz S; Neuro-Oncology Unit, Davidoff Cancer Center at Rabin Medical Center, Petah Tikva, Israel., Welsh L; Neuro-Oncology Unit, The Royal Marsden Hospital, London, UK., Mason WP; Department of Medicine, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Ducray F; Service de Neuro-Oncologie, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Umemura Y; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA., Nabors B; Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA., Holdhoff M; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hottinger AF; Department of Oncology, Lundin Family Brain Tumor Research Centre, University Hospital of Lausanne, Lausanne, Switzerland., Arakawa Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan., Sepulveda JM; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Wick W; Department of Neurology, Universitätsklinikum Heidelberg, Heidelberg & German Cancer Research Center, Heidelberg, Germany., Soffietti R; Department of Neuro-Oncology, University of Turin, Turin, Italy., Perry J; Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Giglio P; Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., de la Fuente M; Department of Neurology, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL, USA., Maher E; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Bottomley A; Bottomley Consulting Group, Brussels, Belgium., Tron AE; Servier Pharmaceuticals, Boston, MA, USA., Yi D; Servier Pharmaceuticals, Boston, MA, USA., Zhao D; Servier Pharmaceuticals, Boston, MA, USA., Pandya SS; Servier Pharmaceuticals, Boston, MA, USA., Steelman L; Servier Pharmaceuticals, Boston, MA, USA., Hassan I; Servier Pharmaceuticals, Boston, MA, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: mellingi@mskcc.org. |
